Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer

Non-Small-Cell Lung Carcinoma

Cancer

Stomach Cancer

Neoplasm Metastasis

Ovarian Cancer

Adenocarcinoma

Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours

activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....

Enrolling

Metastatic Pancreatic Carcinoma

Advanced Pancreatic Carcinoma

Drug: OATD-02

Phase 1

Molecure

Warsaw, Mazowieckie, Poland and 2 other locations

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Active, not recruiting

Breast Cancer

Biliary Cancer

Drug: Camizestrant

Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca

Warsaw, Poland and 67 other locations

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...

Active, not recruiting

Breast Cancer

Colorectal Cancer (CRC)

Drug: Regorafenib

Drug: Capecitabine

Phase 2

Incyte

Warsaw, Poland and 8 other locations

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...

Active, not recruiting

Colorectal Cancer (CRC)

Advanced Solid Tumor

Drug: RMC-6291

Phase 1

Revolution Medicines

Warsaw, Poland and 63 other locations

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting

Breast Cancer

Neuroendocrine Tumors

Drug: Entrectinib

Phase 2

Roche

Warsaw, Poland and 131 other locations

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)

deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors.This study will consist of Part 1 which includes 7 cohorts of: uroth ...

Active, not recruiting

Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer

Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer

Drug: Trastuzumab deruxtecan

Phase 2

AstraZeneca

Warsaw, Poland and 88 other locations

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...

Enrolling

Gastroesophageal Junction Cancer

Gastric Cancer

Drug: l-leucovorin

Drug: Gemcitabine

Phase 2

AstraZeneca

Warsaw, Poland and 51 other locations

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic...

Enrolling

Solid Tumors

Drug: Investigator's choice of chemotherapy

Drug: Placebo

Phase 3

Incyte

Warsaw, Poland and 214 other locations

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic...

Enrolling

Metastatic Pancreatic Ductal Adenocarcinoma

Cachexia

Drug: placebo

Drug: ponsegromab

Phase 2, Phase 3

Pfizer

Warsaw, Masovian Voivodeship, Poland and 205 other locations

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

with nab-p/gem, in participants with untreated metastatic Pancreatic Ductal Adenocarcinoma (PDAC) with homozygous methylthioadenosine phosph...

Active, not recruiting

Pancreatic Ductal Adenocarcinoma

Drug: Placebo

Drug: Nab-paclitaxel

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)

Warsaw, Poland and 269 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Pancreatic Cancer in .css-epvm6{white-space:nowrap;}Warszawa, Mazowieckie

Related conditions:

Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie